Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyBCTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyBCTeam Member asked a question 💭
Lake Norman, North Carolina

I had a lumpectomy and radiation. I have recovered from those things. I just started Herceptin and the hormone blockers.

August 19, 2024
 · 
Reactions
A MyBCTeam Member

Hi Joy, at age 62, I was diagnosed HER2+ Stage 2, Grade 3, one tumor 2.7 cm.

The mammo was late November 2018, and surgery in December,
Chemo (Taxotere, Carboplatin, Herceptin) started Jan 2019
I finished active treatment (continuing Herception infusions every 3 weeks) late January 2020- so far, so good.

A 25% recurrence rate, means a 75% cancer-free rate! Keep the faith! Hugs!

August 19, 2024
A MyBCTeam Member

Thank you so much for the comment. You do not know how much that has helped!

August 19, 2024
MyBCTeam

The chances of HER2-positive breast cancer returning or spreading after treatment with Herceptin (trastuzumab) are influenced by several factors:

- Recurrence Risk: Before targeted therapies like Herceptin, the risk of recurrence within 10 years was between 30% and 50%. With targeted therapy, about 25% of people experience a Show Full Answer

The chances of HER2-positive breast cancer returning or spreading after treatment with Herceptin (trastuzumab) are influenced by several factors:

- Recurrence Risk: Before targeted therapies like Herceptin, the risk of recurrence within 10 years was between 30% and 50%. With targeted therapy, about 25% of people experience a recurrence within 10 years.
- Recurrence Peak: HER2-positive breast cancer has a recurrence peak around 20 months after treatment.
- Factors Increasing Risk: Lymph node involvement, larger tumor size, and diagnosis at age 50 or younger increase the risk of recurrence.

Regular follow-ups and self-exams are crucial for early detection and treatment.

August 19, 2024

Related Questions

View All
A MyBCTeam Member asked a question 💭
Tucson, AZ